**Strong IPO momentum in 2026, fueled by record proceeds and a reopened window for growth companies, is shaping trader sentiment around which issuers will complete listings by year-end.** Through mid-2026, U.S. IPOs raised over $150 billion, led by SpaceX’s $86 billion debut and supported by broader equity issuance exceeding prior years, amid favorable valuations and investor demand for AI and technology names. Multiple companies have priced or filed for September and October 2026 debuts, including Holtec Nuclear, Orion180 Insurance, Electra Therapeutics, and Bamboo Insurance, with additional candidates like Anthropic advancing toward potential Q4 timing. Market-implied probabilities reflect this pipeline, with near-term catalysts such as pricing dates and roadshows likely to drive further shifts in consensus before December 31 resolution.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedMistral AI closes €3 billion funding round at €21 billion valuation
Mistral AI completed a €3 billion Series D funding round in September 2026, raising its valuation to approximately €21 billion (~$24 billion). The company confirmed IPO remains a long-term possibility but no immediate plans or filings have been made.
Mistral AI raises €3 billion at €20 billion valuation, plans IPO after 2026
Mistral AI drops to 5%5%
Mistral AI closed a €3 billion funding round in mid-2026 at a €20 billion valuation, nearly doubling its previous valuation. The company confirmed IPO plans but indicated the listing would likely occur after 2026, focusing on scaling and strategic partnerships in the meantime.
































Beware of external links.
Beware of external links.
Frequently Asked Questions